RNA specialist Wave Life Sciences has been told by Takeda that the Japanese drugmaker is to bring to an end the last facet of ...

This week’s news from the life sciences includes Eli Lilly's investment in a Cambridge-Singapore biotech, Stealth ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on ...

Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...

Wave Life Sciences (WVE) said Takeda (TAK) has elected not to exercise its option to further develop its Huntington’s disease ...

Takeda is walking away from the last target in a collaboration with Wave Life Scien | Takeda has brandished a termination ...

Takeda Pharma in May inked an up-to-$1.2 billion, plus royalties, partnership with Degron Therapeutics to develop molecular glue-based therapies for unspecified “multiple” indications in glue ...

Governor Maura Healey on Tuesday announced $21.4 million in tax incentives for life sciences companies that are expected to create 1,155 jobs in the state.

There is no simple solution to tackling health inequity, but we’re confident that infusing health equity principles across ...

There may be no greater demonstration of vaccines’ power to deliver health equity than their success with smallpox. “The ...